Multimodal Imaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Multimodal Imaging Market is Segmented by Technology (PET/CT Systems, SPECT/CT Systems, PET/MR Systems, Others) Application, End-User, and Geography

Market Snapshot

Multimodal Imaging Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The multimodal imaging market was expected to expand with a CAGR of nearly 5.2% during the forecast period. The major factors attributing to the growth of the multimodal imaging market are the growing incidence of chronic diseases like cancer, cardiac disorders, etc., and the increasing geriatric population globally. 

According to the United Nations, the number of people aged above 60 years is expected to double by the year 2050, rising from 962 million globally in 2017 to 2.1 billion in 2050. Furthermore, the advancements in the diagnostic imaging, like using artificial intelligence in CT scans and growing health expenditure is a constructive sign for any medical device market including multimodal imaging systems, the adoption of advanced tools and equipment comprising multimodal imaging systems for diagnostics and research applications is growing in developing regions, which drive the market growth. 

However, the high cost of multimodal imaging systems and lack of appropriate healthcare infrastructure are the factors restraining the market.

Scope of the Report

As per the scope of the report, multimodal imaging systems describe to concurrent production of signals from more than one imaging technique. Multimodal imaging facilitates analyzing more than one molecule at a time so that cellular processes can be analyzed at the same time or the progression of these events can be monitored in present.

By Technology
PET/CT Systems
SPECT/CT Systems
PET/MR Systems
Others
By Application
Oncology
Ophthalmology
Cardiology
Others
By End-User
Hospitals
Diagnostic Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

PET/CT Systems Segment is Expected to be the Fastest Growing Segment During the Forecast Period

PET scan can be used to inspect the blood flow, oxygen intake, or the metabolism of organs and tissues. PET scans reveal problems at the cellular level, giving the best view of complex systemic diseases. It is majorly used to detect malignancies.

The PET/CT systems segment is expected to be the fastest-growing segment of the multimodal imaging techniques market. This can be credited to the increasing demand for early and accurate cancer diagnosis, expanding clinical evidence for the early diagnosis of Alzheimer’s disease, increasing the use of PET/CT systems in cardiology, and many other diseases. Furthermore, good reimbursement situations and technological improvements in the field of PET/CT are a few other reasons for the segment to lead the market.

Picture1.png

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall multimodal imaging market, throughout the forecast period. The market growth is due to factors such as the high prevalence of chronic diseases like cancer, cardiovascular diseases in the region, and well-established insurance policies and the availability of advanced healthcare infrastructure are some of the key factors accountable for its large share in the market. 

In the North America region, the United States holds the largest market share due to factors such as an increasing number of geriatric populations, a large patient pool in the country, is anticipated to stimulate the demand in this region. According to the American Cancer Society, about 606,880 Americans are expected to die of cancer in 2019, which means 1,660 deaths per day. With the growing incidence of chronic diseases and due to the rapid adoption of technologically advanced imaging systems, the market flourishes in the region.

Picture3.png

Competitive Landscape

The multimodal imaging market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Mediso Ltd., Neusoft Medical Systems Co., Ltd., Spectrum Dynamics Medical and others.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Prevalence of Chronic Illness

      2. 4.2.2 Technological Advancements in Diagnostic Imaging Modalities

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Multimodal Imaging Systems

      2. 4.3.2 Shortage of Adequate Healthcare Infrastructure

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Technology

      1. 5.1.1 PET/CT Systems

      2. 5.1.2 SPECT/CT Systems

      3. 5.1.3 PET/MR Systems

      4. 5.1.4 Others

    2. 5.2 By Application

      1. 5.2.1 Oncology

      2. 5.2.2 Ophthalmology

      3. 5.2.3 Cardiology

      4. 5.2.4 Others

    3. 5.3 By End-User

      1. 5.3.1 Hospitals

      2. 5.3.2 Diagnostic Centers

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 GE Healthcare

      2. 6.1.2 Siemens Healthineers

      3. 6.1.3 Koninklijke Philips N.V.

      4. 6.1.4 Mediso Ltd.

      5. 6.1.5 Neusoft Medical Systems Co. Ltd

      6. 6.1.6 Spectrum Dynamics Medical

      7. 6.1.7 MILabs B.V.

      8. 6.1.8 Bruker Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Multimodal Imaging Market market is studied from 2018 - 2026.

The Multimodal Imaging Market is growing at a CAGR of 5.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

GE Healthcare, Siemens Healthineers AG, Koninklijke Philips N.V., Mediso Ltd., Spectrum Dynamics Medical are the major companies operating in Multimodal Imaging Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!